-
1دورية أكاديمية
المؤلفون: Kumar Ajay, Gill Simranpreet Singh, Singh Gurpreet, Sharma Shubham, Dwivedi Shashi Prakash, Mohammed Kahtan A., Sharma Kuldeep, Kozak Dražan, Hunjet Anica, Abbas Mohamed
المصدر: High Temperature Materials and Processes, Vol 43, Iss 1, Pp pp. 610-616 (2024)
مصطلحات موضوعية: dry machining, minimum quantity lubrication, nano-mql, rsm, anova, turning, Technology, Chemical technology, TP1-1185, Chemicals: Manufacture, use, etc., TP200-248
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2191-0324
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
المؤلفون: Campbell James, Siddiqui Salman, Gill Simon, Tsamis Alkiviadis
المصدر: MATEC Web of Conferences, Vol 349, p 03008 (2021)
مصطلحات موضوعية: Engineering (General). Civil engineering (General), TA1-2040
وصف الملف: electronic resource
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
المؤلفون: Connor MP; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania. matthew.connor@pennmedicine.upenn.edu., Prathapa N; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Frey NV; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Gill SI; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Hexner EO; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Bruno XJ; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Lai CE; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Loren AW; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Luger SM; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Matthews AH; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., McCurdy SR; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Perl AE; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Porter DL; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Zeringue A; Information Services, University of Pennsylvania., Oved JH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia., Olson TS; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA; Department of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia., Pratz KW; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania., Babushok DV; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA; Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia. daria.babushok@pennmedicine.upenn.edu.
المصدر: Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2732-2737. Date of Electronic Publication: 2024 Aug 01.
نوع المنشور: Letter; Journal Article
بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
مواضيع طبية MeSH: Anemia, Aplastic*/drug therapy , Anemia, Aplastic*/chemically induced, Humans ; Male ; Female ; Middle Aged ; Aged ; Neoplasms, Second Primary/etiology ; Adult ; Antimetabolites, Antineoplastic/adverse effects ; Antimetabolites, Antineoplastic/therapeutic use ; Azacitidine/adverse effects ; Azacitidine/therapeutic use ; DNA Methylation/drug effects ; Aged, 80 and over ; Myelodysplastic Syndromes/drug therapy
-
6دورية أكاديمية
المؤلفون: Wellhausen N; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Baek J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gill SI; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Saar.Gill2@pennmedicine.upenn.edu.; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Saar.Gill2@pennmedicine.upenn.edu.; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, University of Pennsylvania, Philadelphia, PA, USA. Saar.Gill2@pennmedicine.upenn.edu., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
المصدر: Nature reviews. Cancer [Nat Rev Cancer] 2024 Jul 24. Date of Electronic Publication: 2024 Jul 24.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE
-
7دورية أكاديمية
المؤلفون: Kang Y; Division of Cardiovascular Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Lefebvre B; Division of Cardiovascular Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Pamies IM; Division of Cardiovascular Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Gill SI; Division of Hematology and Oncology Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Doucette AG; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Denduluri S; Division of Cardiovascular Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Smith AM; Division of Cardiovascular Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Division of Hematology and Oncology Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., McCurdy S; Division of Hematology and Oncology Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Luger S; Division of Hematology and Oncology Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Carver J; Division of Cardiovascular Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Scherrer-Crosbie M; Division of Cardiovascular Disease, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Marielle.Scherrer-Crosbie@pennmedicine.upenn.edu.
المصدر: The American journal of cardiology [Am J Cardiol] 2024 Jul 06; Vol. 226, pp. 9-17. Date of Electronic Publication: 2024 Jul 06.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0207277 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1913 (Electronic) Linking ISSN: 00029149 NLM ISO Abbreviation: Am J Cardiol Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Chippendale L; Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Freyer CW; Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Carulli A; Department of Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Babushok DV; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Frey NV; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Gill SI; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Hexner EO; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Luger SM; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Martin ME; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Porter DL; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Stadtmauer EA; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Loren AW; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 802-810. Date of Electronic Publication: 2023 Aug 21.
نوع المنشور: Journal Article; Comparative Study
بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
مواضيع طبية MeSH: Busulfan*/administration & dosage , Busulfan*/pharmacokinetics , Hematopoietic Stem Cell Transplantation*/methods , Drug Monitoring*/methods , Transplantation Conditioning*/methods , Graft vs Host Disease*/prevention & control , Transplantation, Homologous*, Humans ; Male ; Female ; Middle Aged ; Adult ; Retrospective Studies ; Aged ; Young Adult ; Disease-Free Survival ; Myeloablative Agonists/administration & dosage ; Myeloablative Agonists/pharmacokinetics ; Myeloablative Agonists/therapeutic use
-
9دورية أكاديمية
المؤلفون: Sung AD; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Koll T; Division of Geriatrics, Gerontology, and Palliative Medicine, University of Nebraska Medical Center, Omaha, NE., Gier SH; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Racioppi A; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., White G; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Lew M; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Free M; Division of Geriatrics, Gerontology, and Palliative Medicine, University of Nebraska Medical Center, Omaha, NE., Agarwal P; Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska., Bohannon LM; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Johnson EJ; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Selvan B; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Babushok DV; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Frey NV; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Gill SI; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Hexner EO; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Martin M; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Perl AE; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Pratz KW; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Luger SM; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Chao NJ; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Fisher AL; Division of Geriatrics, Gerontology, and Palliative Medicine, University of Nebraska Medical Center, Omaha, NE., Stadtmauer EA; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Porter DL; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Loren AW; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania., Bhatt VR; Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska., Gimotty PA; Department of Biostatistics, Epidemiology and Informatics Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., McCurdy SR; Division of Hematology and Oncology, Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: shannon.mccurdy@pennmedicine.upenn.edu.
المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Apr; Vol. 30 (4), pp. 415.e1-415.e16. Date of Electronic Publication: 2024 Jan 17.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
مواضيع طبية MeSH: Frailty* , Hematopoietic Stem Cell Transplantation* , Leukemia, Myeloid, Acute*, Humans ; Aged ; Middle Aged ; Recurrence ; Transplantation, Homologous
-
10دورية أكاديمية
المؤلفون: Freyer CW; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Carulli A; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Frey NV; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Gill SI; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Hexner EO; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Martin ME; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Luger SM; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Porter DL; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Stadtmauer EA; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Loren AW; Blood and Marrow Transplant and Cellular Therapy Program, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Feb; Vol. 65 (2), pp. 250-256. Date of Electronic Publication: 2024 Jan 24.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
مواضيع طبية MeSH: Calcineurin Inhibitors* , Hematopoietic Stem Cell Transplantation*, Humans ; Retrospective Studies ; Tacrolimus ; Diclofenac